Skip to content
healthcare.dev

ZORYVE

NDC 80610-430, roflumilast, aerosol, foam, from Arcutis Biotherapeutics, Inc..

Product NDC
80610-430
Status
Listed
Labeler
Arcutis Biotherapeutics, Inc.
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217242
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80610-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST3 mg/g

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
80610-430-60806100430601 CAN in 1 CARTON (80610-430-60) / 60 g in 1 CAN

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f9e0b4a9-a227-4947-b00c-41fb18d16589
  • NADAC price for package 80610043060

    GET /v1/drugs/nadac/80610043060

Use it

Look up 80610-430 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80610-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80610-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.